Recent
advancements in therapeutic approaches targeting tyrosine
kinase 2 (TYK2) have shown promising results across various medical
fields, including oncology and immunology. TYK2, a Janus kinase (JAK)
family member, plays a significant role in cytokine signaling and
immune regulation. This Patent Highlight explores the latest developments
in TYK2 inhibitors, highlighting their potential in treating diverse
conditions such as cancer, alopecia areata, and psoriatic arthritis.